MBRX
Moleculin Biotech
$8.72
−$0.03 (−0.29%)Oct 29, 2026
Key metrics
The numbers that frame MBRX today
- Market cap
- $8.49M
- ROIC
- 610.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.23
- 52wk High
- $315.00
Growth
Revenue and earnings trend for MBRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MBRX
Is Moleculin Biotech a good buy?
No. Moleculin Biotech has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Moleculin Biotech is selling at a very high price.
What is the market capitalization of MBRX?
Moleculin Biotech's market capitalization is $8.49M.
What is the 52-week high for MBRX stock?
The 52-week high for Moleculin Biotech is $315.00. The current close of $8.72 is 97.2% below that high.
What is the 52-week low for MBRX stock?
The 52-week low for Moleculin Biotech is $3.23. The current close of $8.72 is 170.1% above that low.
Does MBRX stock pay dividends?
Moleculin Biotech does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MBRX?
Moleculin Biotech's Debt / Equity ratio is 0.01.